首页> 美国卫生研究院文献>Scientific Reports >On–off switching of cell cycle and melanogenesis regulation of melanocytes by non-thermal atmospheric pressure plasma-activated medium
【2h】

On–off switching of cell cycle and melanogenesis regulation of melanocytes by non-thermal atmospheric pressure plasma-activated medium

机译:非热常压等离子体激活培养基的开-关切换和黑色素细胞的黑色素生成调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-thermal atmospheric pressure (NAP) plasma has demonstrated potential in biomedical applications, such as cancer treatment, bactericidal sterilization, and cell growth promotion or inhibition. In this study, for the first time, we demonstrated on–off switching of cell cycle progression and regulated melanogenesis in normal human skin melanocytes by NAP plasma-activated medium (PAM). The melanocytes were exposed to NAP plasma at durations varying from 0 to 20 min, and the effects of PAM on cell proliferation, cell cycle progression, and melanogenesis were investigated. Although PAM showed no cytotoxicity, the proliferation of melanocytes was inhibited. The melanocyte cell cycle was arrested by PAM for a relatively short period (48 h), after which it recovered slowly. PAM promoted melanogenesis through the activation of the enzymes tyrosinase, tyrosinase-related protein-1, and tyrosinase-related protein-2. These effects seem to be related to reactive oxygen species induced by PAM. Our finding that PAM modulates the cell cycle may provide insight into the recurrence of cancer. The regulation of the melanogenesis of melanocytes may facilitate the control of skin tone without incurring negative side effects.
机译:非热大气压力(NAP)血浆在生物医学应用中已显示出潜力,例如癌症治疗,杀菌灭菌以及促进或抑制细胞生长。在本研究中,我们首次展示了NAP血浆激活培养基(PAM)在正常人皮肤黑色素细胞中的细胞周期进程的开关控制和黑色素生成的调控。黑色素细胞暴露于NAP血浆中的时间为0到20分钟,研究PAM对细胞增殖,细胞周期进程和黑色素生成的影响。尽管PAM没有显示出细胞毒性,但是黑素细胞的增殖被抑制了。黑色素细胞周期被PAM停滞了相对较短的时间(48 h),之后缓慢恢复。 PAM通过激活酪氨酸酶,酪氨酸酶相关蛋白1和酪氨酸酶相关蛋白2来促进黑色素生成。这些作用似乎与PAM诱导的活性氧有关。我们对PAM调节细胞周期的发现可能提供对癌症复发的见解。黑色素细胞黑色素生成的调节可以促进肤色控制,而不会产生负面副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号